Low-dose hormone therapy may be beneficial in postmenopausal women with myocardial ischaemia but no obstructive coronary artery disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1614, 2007-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of acadesine on myocardial ischaemia in patients with coronary artery disease

By de Jonge R.   Macleod D.C.   Suryapranata H.   van Es G.A.   Friedman J.   Serruys P.W.   de Jong J.W.  

European Journal of Pharmacology, Vol. 337, Iss. 1, 1997-10 ,pp. : 41-44

Elsevier

Access to resources Recommend Favorite

VEGF gene therapy appears beneficial in myocardial ischaemia

By  

Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Low-dose testosterone therapy improves body composition and sexual function in men with chronic obstructive pulmonary disease

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Low-dose estrogens prevent bone loss in postmenopausal women

By  

Inpharma, Vol. 1, Iss. 1340, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Celecoxib: beneficial effects in coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite